港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

中慧生物-B

51.500

+1.6603.33%

成交量：44.52萬

成交額：2,226.88萬

市值：202.62億

市盈率：-65.77

高：52.300

開：49.820

低：48.580

收：49.840

52周最高：59.600

52周最低：33.000

股本：3.93億

香港流通股本：2.96億

量比：0.47

換手率：0.15%

股息：- -

股息率：- -

每股收益(LYR):-0.783

淨資產收益率：--

總資產收益率：--

市淨率：299.09

市盈率(LYR):-65.77

市銷率: 71.60

資料載入中...

總覽公司新聞公告

中國資產全面爆發！港股打新最高漲近300%

老虎资讯综合

港股異動 | 中慧生物-B(02627)漲超7% 重組呼吸道合胞病毒疫苗IND申請中美雙報獲批

中慧生物-B(02627)：重組呼吸道合胞病毒疫苗(CHO細胞)(佐劑)的IND獲中國CDE及美國FDA批准

港股IPO週報：港股18A打新浪潮迴歸！中慧生物-B、銀諾醫藥-B上市首日大漲

異動解讀 | 中慧生物-B股價盤中大跌5.13%，疑因大宗交易拋售

港股生物醫藥概念股強勢拉昇，中慧生物-B、北海康成-B漲超30%

老虎资讯综合

港股異動 | 中慧生物-B(02627.HK)再漲超20% 四價流感病毒亞單位疫苗入選商保創新藥目錄初審名單

異動解讀 | 中慧生物-B盤中大漲5.72%，四價流感疫苗入選國家醫保創新藥品初審名單

中慧生物旗下慧爾康欣作為唯一疫苗入選國家醫保創新藥品初審名單

老虎资讯综合

市值超170億港元，三大邏輯揭示中慧生物-B(02627.HK)的資本熱潮

市值超170億港元，三大邏輯揭示中慧生物-B的資本熱潮

中慧生物-B(02627)旗下慧爾康欣®作為唯一疫苗入選國家醫保創新藥品初審名單

從4000倍瘋搶到單日暴漲158%，中慧生物-B（02627）成全球黑天鵝對沖新硬通貨？

中慧生物-B08月12日主力淨流入969.5萬元散戶資金拋售

中慧生物-B尾盤漲幅擴大至30%，上市兩日累漲逾230%

老虎资讯综合

異動解讀 | 中慧生物-B上市次日再度大漲24.88%，兩日累漲超200%

一個醫藥IPO開盤漲150%：中慧生物市值超130億

長春高新、天壇生物等：多藥企藥品進展及業績情況更新

港股異動 | 中慧生物-B(02627.HK)上市次日再漲超20% 昨日飆升近158% 總市值突破150億港元

每日醫刻｜醫療器械概念股震盪走強三鑫醫療、賽諾醫療雙雙漲超10%；復星醫藥DPP-1抑制劑授權出海

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02627/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":51.5,"timestamp":1755850090168,"preClose":49.84,"halted":0,"volume":445200,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.7830232300622129,"marketStatus":"未開盤","change":1.66,"latestTime":"08-22 16:08:10","open":49.82,"high":52.3,"low":48.58,"amount":22268842,"amplitude":0.074639,"askPrice":51.5,"askSize":5200,"bidPrice":51.15,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.8556189425704193,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1756085400000},"marketStatusCode":0,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":49.84,"openAndCloseTimeList":[[1755826200000,1755835200000],[1755838800000,1755849600000]],"volumeRatio":0.47423857654256635,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.783023,"volumeRatio":0.47423857654256635,"shares":393442600,"dividePrice":0,"high":52.3,"amplitude":0.074639,"preClose":49.84,"low":48.58,"week52Low":33,"pbRate":"299.09","psRate":"71.60","week52High":59.6,"institutionHeld":0,"latestPrice":51.5,"committee":-0.677419,"eps":-0.7830232300622129,"divideRate":0,"volume":445200,"delay":0,"ttmEps":-0.8556189425704193,"open":49.82,"prevYearClose":12.9,"prevWeekClose":51.5,"prevMonthClose":12.9,"prevQuarterClose":12.9,"fiveDayClose":47.18,"twentyDayClose":12.9,"sixtyDayClose":12.9,"earningDate":1756310400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2025-08-22","current":-65.870069,"percent":0.3,"low":-68.430715,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"high":-18.07815,"avg":-57.072742,"sd":14.173794,"marketCap":20262293900},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900}],"updateTime":1756023268200},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141757368","title":"中國資產全面爆發！港股打新最高漲近300%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141757368","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141757368?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 11:05","pubTimestamp":1755572712,"startTime":"0","endTime":"0","summary":"8月19日，中国资产全面爆发，A股沪指创近10年新高！港股IPO持续势如破竹，7月以来上市12支，首日10支收涨，2支收跌，胜率高达83.33%！累计一手收益可达15,367港元。📢 双登股份（06960）正在火热申购中🔥🚩 申购方式：【老虎国际App】-【持仓】-【IPO】✨ 老虎打新优势：✅ 现金申购0手续费，融资申购0孖展利息✅ 10倍杠杆，额度充足✅ 支持暗盘交易，快人一步抢占先机✅ TOP科技券商，安全可靠","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"中国资产全面爆发！港股打新最高涨近300%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","02627","06960","02591"],"gpt_icon":0},{"id":"2560597557","title":"港股異動 | 中慧生物-B(02627)漲超7% 重組呼吸道合胞病毒疫苗IND申請中美雙報獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2560597557","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560597557?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 09:45","pubTimestamp":1755481551,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中慧生物-B涨超7%，截至发稿，涨7.25%，报50.6港元，成交额1364.46万港元。消息面上，中慧生物公告，集团自主研发的重组呼吸道合胞病毒疫苗(佐剂)的新药临床试验申请已经获得国家药品监督管理局药品审评中心批准。公告指出，集团的重组呼吸道合胞病毒疫苗(佐剂)利用CHO细胞研制而成，可表达经修饰的pre-F蛋白。集团经广泛筛选获得了能够稳定表达pre-F蛋白的高产量单克隆细胞系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"683842b7a5459c08a27a9a79e085b6a5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","159646"],"gpt_icon":0},{"id":"2560922523","title":"中慧生物-B(02627)：重組呼吸道合胞病毒疫苗(CHO細胞)(佐劑)的IND獲中國CDE及美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560922523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560922523?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 19:26","pubTimestamp":1755429967,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，集团自主研发的重组呼吸道合胞病毒疫苗(佐剂)的新药临床试验申请已经获得国家药品监督管理局药品审评中心批准。呼吸道合胞病毒作为一种高传染性RNA病毒，是导致婴儿、老年人和免疫功能不全者呼吸道感染的重要病原体之一。严重病例可危及生命。集团的重组呼吸道合胞病毒疫苗(佐剂)利用CHO细胞研制而成，可表达经修饰的pre-F蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","LU1223082519.USD","BK4017","CDE","LU1223082196.USD","LU1223083913.SGD","02627"],"gpt_icon":1},{"id":"2560924481","title":"港股IPO週報：港股18A打新浪潮迴歸！中慧生物-B、銀諾醫藥-B上市首日大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2560924481","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560924481?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 17:00","pubTimestamp":1755421200,"startTime":"0","endTime":"0","summary":"最近一周，两家18A中慧生物-B、银诺医药-B正式上市，首日表现相当亮眼，分别涨157.98%、206.48%，今年港股18A生物科技公司IPO赚钱效应显著，打新热潮强势回归。中慧生物-B上市首日股价大幅高开156%，早盘一度冲高至170%，而后持续于高位震荡，最终收盘涨157.98%，全天成交近900万股，成交额约2.98亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-08-17/doc-infmhrpc0843581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSCEI","HSTECH","BK4614","02627","02591","YANG"],"gpt_icon":1},{"id":"1111748033","title":"異動解讀 | 中慧生物-B股價盤中大跌5.13%，疑因大宗交易拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=1111748033","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111748033?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 09:47","pubTimestamp":1755136058,"startTime":"0","endTime":"0","summary":"周四盘中，港股中慧生物-B（02627）股价出现大幅下跌，跌幅高达5.13%，引发市场关注。\n\n根据市场信息，该股在上午9时左右出现一笔大宗交易，卖出量为60万股，成交价为52.2港元，涉及资金达3132万港元。这笔大额抛售可能是导致股价下跌的主要原因，反映出部分大型投资者可能正在调整持仓或对公司未来发展持谨慎态度。\n\n截至目前，中慧生物-B今日的最高价和最低价均为52.2港元，总成交量达110万股，成交金额约5742万港元。这一大宗交易占据了当日总成交量的超过一半，显示出其对股价走势的重要影响。投资者应密切关注后续可能出现的公司公告或市场消息，以更好地理解此次股价变动的深层原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":0},{"id":"1187244558","title":"港股生物醫藥概念股強勢拉昇，中慧生物-B、北海康成-B漲超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187244558","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187244558?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 10:01","pubTimestamp":1755050488,"startTime":"0","endTime":"0","summary":"8月13日，港股生物医药概念股强势拉升，$中慧生物-B(02627)$、$北海康成-B(01228)$涨超30%，$派格生物医药-B(02565)$涨近9%，$荃信生物-B(02509)$涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eea96c2db952be4ad0141d428041d6b9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","02565","09939","BK1161","01228","02509"],"gpt_icon":0},{"id":"2559673494","title":"港股異動 | 中慧生物-B(02627.HK)再漲超20% 四價流感病毒亞單位疫苗入選商保創新藥目錄初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2559673494","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559673494?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:43","pubTimestamp":1755049381,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","159646","06978","159992","02627","BK1161"],"gpt_icon":0},{"id":"1119727961","title":"異動解讀 | 中慧生物-B盤中大漲5.72%，四價流感疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1119727961","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119727961?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:33","pubTimestamp":1755048780,"startTime":"0","endTime":"0","summary":"中慧生物-B今日盘中大涨5.72%，引发市场关注。消息面上，公司旗下四价流感病毒亚单位疫苗获纳入2025年度国家商业健康保险创新药品目录通过初步审查的名单，成为当中唯一一款疫苗产品。分析人士认为，慧尔康欣作为唯一疫苗产品入选国家医保创新药品初审名单，有望进一步提升其市场竞争力和销售前景。此外，这一消息也反映了中慧生物-B在创新疫苗研发和商业化方面的实力，有助于增强投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":1},{"id":"1163046330","title":"中慧生物旗下慧爾康欣作為唯一疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1163046330","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163046330?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:31","pubTimestamp":1755048719,"startTime":"0","endTime":"0","summary":"8月13日，$中慧生物-B(02627)$盘初再飙逾15%，总市值超200亿港元！旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"feece2e65780deb9a483e9ba56c7acc5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中慧生物旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"2559678586","title":"市值超170億港元，三大邏輯揭示中慧生物-B(02627.HK)的資本熱潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2559678586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559678586?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:36","pubTimestamp":1755045414,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02627","BK4614","HSTECH","YANG","07226","HSCEI","HEXmain"],"gpt_icon":0},{"id":"2559678580","title":"市值超170億港元，三大邏輯揭示中慧生物-B的資本熱潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2559678580","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559678580?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:36","pubTimestamp":1755045414,"startTime":"0","endTime":"0","summary":"当8月11日$港交所$的铜锣敲响，$中慧生物-B$瞬间点燃资本市场的热情。中慧生物股此次上市的火爆早有预兆。公开发售阶段19.1万人疯抢，超额认购倍数达4007倍，冻结资金超过2100亿港元，成为年内18A生物科技板块无可争议的“超购王”。值得一提的是，在中慧生物的募资计划中预留了战略性并购冗余度，超10%资金可用于横向整合。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328846.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2559620416","title":"中慧生物-B(02627)旗下慧爾康欣®作為唯一疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2559620416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559620416?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:20","pubTimestamp":1755044428,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，根据国家医疗保障局于2025年8月12日发布的公告，本年度国家商业健康保险创新药品目录通过初步审查的名单中，包括唯一一款疫苗产品—四价流感病毒亚单位疫苗。该产品在传统病毒裂解疫苗的基础上进行重大升级，具有保护全面、组分抗原纯度高、不良反应风险低等优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"feece2e65780deb9a483e9ba56c7acc5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","159646"],"gpt_icon":0},{"id":"2559930623","title":"從4000倍瘋搶到單日暴漲158%，中慧生物-B（02627）成全球黑天鵝對沖新硬通貨？","url":"https://stock-news.laohu8.com/highlight/detail?id=2559930623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559930623?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 23:54","pubTimestamp":1755014086,"startTime":"0","endTime":"0","summary":"当2025年8月11日港交所的铜锣敲响，中慧生物-B瞬间点燃资本市场的热情。这只新股以12.9港元发行价开盘，最高飙升近170%，最终收盘定格于33.28港元，单日暴涨157.98%，一举创下2025年港股新股首日涨幅最高纪录。次日，中慧生物股价继续狂飙，大涨31.31%，市值突破170亿港元。中慧生物股此次上市的火爆早有预兆。除了上述两大逻辑外，中慧生物被全球长线基金们爆买的另一个原因可能是中国创新药疫苗龙头对冲全球黑天鹅事件的对冲策略。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2558561043","title":"中慧生物-B08月12日主力淨流入969.5萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2558561043","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558561043?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 16:15","pubTimestamp":1754986534,"startTime":"0","endTime":"0","summary":"08月12日, 中慧生物-B股价涨31.31%，报收43.70元，成交金额1.7亿元，换手率1.43%，振幅31.19%，量比0.00。该股近5个交易日上涨237.21%，主力资金累计净流入969.5万元；近20日主力资金累计净流入969.5万元，其中净流入天数为1日。该股主力净额占比0.07%，港股市场排名99/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165910a483bb27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165910a483bb27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627"],"gpt_icon":0},{"id":"1165906624","title":"中慧生物-B尾盤漲幅擴大至30%，上市兩日累漲逾230%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165906624","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165906624?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 15:50","pubTimestamp":1754985029,"startTime":"0","endTime":"0","summary":"8月12日，$中慧生物-B(02627)$上市次日续涨近5%，该股昨日上市首日大幅收涨近158%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"1198395305","title":"異動解讀 | 中慧生物-B上市次日再度大漲24.88%，兩日累漲超200%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198395305","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198395305?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 15:43","pubTimestamp":1754984583,"startTime":"0","endTime":"0","summary":"8月12日，中慧生物-B延续上市首日的强势表现，盘中大涨24.88%，报41.56港元。截至发稿，该股涨幅收窄至19.35%，报39.72港元。加上昨日157.98%的涨幅，中慧生物-B上市两日累计涨幅已突破200%，总市值超过150亿港元。中慧生物-B于8月11日在港交所主板挂牌上市，发行价为12.9港元/股。公开资料显示，中慧生物致力于疫苗的研发、制造及商业化。尽管中慧生物-B上市后表现亮眼，但投资者仍需关注公司的长期发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":0},{"id":"2558934614","title":"一個醫藥IPO開盤漲150%：中慧生物市值超130億","url":"https://stock-news.laohu8.com/highlight/detail?id=2558934614","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558934614?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 14:27","pubTimestamp":1754980044,"startTime":"0","endTime":"0","summary":"早在2019年4月，中慧生物完成1.3亿元A轮融资，南京高特佳、泰州金泰弘毅基金参投。为应对内卷，中慧生物加大产品推广力度，慧尔康欣在全国30个省份完成市场准入，获超过1100家区县级疾控中心选用。最新一幕出现在上周，北海康成意外成为港股生物医药板块的领头羊，最高涨幅超过30%。7月底，其港股单日市值暴涨超1100亿港元，总市值突破5600亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143008a4836f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143008a4836f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627","BK1574","BK1515","09939"],"gpt_icon":1},{"id":"2558135446","title":"長春高新、天壇生物等：多藥企藥品進展及業績情況更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2558135446","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558135446?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 12:12","pubTimestamp":1754971969,"startTime":"0","endTime":"0","summary":"2024年4月首批296种药品获批，2025年8月8日第二批249种药品获批，可在新街坊卫生站供澳门居民使用。目前共有367种、545个品规药品可供使用。8月11日，长春高新公告，子公司金赛药业卡麦角林片临床试验申请获批，国内尚无同品种产品上市，将推动后续开发。8月8日，星昊医药公告，2025半年度营业收入3.08亿元，同比降4.08%；净利润4108万元，同比降32.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812122035a4833a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812122035a4833a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK0057","BK0075","BK0082","BK0010","02196","BK0046","BK0028","BK0168","BK0239","MRK","600161","000661","02627","688029","BK0185","BK0188"],"gpt_icon":0},{"id":"2558528690","title":"港股異動 | 中慧生物-B(02627.HK)上市次日再漲超20% 昨日飆升近158% 總市值突破150億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558528690","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558528690?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 11:03","pubTimestamp":1754967825,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d71e634b2f4acf7c3815ac7007e4a034","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02627"],"gpt_icon":0},{"id":"2558961822","title":"每日醫刻｜醫療器械概念股震盪走強 三鑫醫療、賽諾醫療雙雙漲超10%；復星醫藥DPP-1抑制劑授權出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2558961822","media":"财健道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558961822?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 10:47","pubTimestamp":1754966860,"startTime":"0","endTime":"0","summary":"将“财健道”设为星标持续关注，不错过好看每日医刻1医疗器械概念股震荡走强 三鑫医疗、赛诺医疗双双涨超10%8月12日开盘，三鑫医疗、赛诺医疗双双涨超10%，麦澜德、中红医疗、正海生物、山外山、戴维医疗、南微医学等涨超5%。3复星医药DPP-1抑制剂授权出海8月11日，复星医药宣布其控股子公司复星医药产业与Expedition签订许可协议，授予后者在除中国境内及港澳地区以外地区开发、生产及商业化XH-S004的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812113038a483262b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812113038a483262b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1593","02627","BK1574","688108","09995","BK1515","688331","BK1100","09997","BK1191","BK1222","BK1583","600196","02196"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":89,"code":"91000000","status":"200"}]}}